Bloomfield, NJ, United States of America

Richard E Chipkin


Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1981-1986

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Richard E Chipkin: Innovator in Pain Management

Introduction

Richard E Chipkin, based in Bloomfield, NJ, is a distinguished inventor known for his contributions in the field of pharmaceutical innovations. With a total of 2 patents to his name, Chipkin has significantly advanced methods for treating pain and inflammation.

Latest Patents

Chipkin's latest patents focus on innovative therapeutic compositions. The first patent encompasses methods of treating pain and inflammation using the compound 4,7-dimethyl-2-(4-pyridinyl)-1,2,4-triazolo[1,5-a]pyrimidin-5(4H)-one and its pharmaceutically acceptable salts, recognized as effective analgesic and anti-inflammatory agents. His second patent details a class of tetrapeptides having opiate activity, providing further advancement in pain management therapies.

Career Highlights

Throughout his career, Richard E Chipkin has made notable strides while working with esteemed companies in the pharmaceutical sector, including Pennwalt Corporation and Schering Corporation. His efforts have contributed to significant developments in drug formulations and therapeutic applications.

Collaborations

Chipkin has collaborated with reputable professionals in his field, including colleagues John M Stewart and Dan H Morris. These partnerships have fostered a productive environment for innovation and have led to comprehensive advancements in pain treatment methodologies.

Conclusion

Richard E Chipkin stands as an influential figure in pharmaceutical innovation, dedicated to enhancing pain management techniques through his inventive contributions. His patents not only highlight his expertise but also represent a commitment to improving patient care and therapeutic outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…